+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pre-Exposure Prophylaxis Market - Global Forecast 2025-2030- Product Image
Pre-Exposure Prophylaxis Market - Global Forecast 2025-2030- Product Image
Sale

Pre-Exposure Prophylaxis Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6117479
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pre-exposure prophylaxis (PrEP) plays a pivotal role in global preventative healthcare strategies, enabling at-risk individuals to access effective HIV prevention tools. The market has evolved rapidly, shaped by regulatory changes, technological progress, and the urgent call for inclusive public health solutions. Senior decision-makers will find this report instrumental in understanding the diverse dynamics and strategic imperatives within the PrEP landscape.

Market Snapshot: Pre-Exposure Prophylaxis Market Overview

The pre-exposure prophylaxis market is witnessing robust expansion, driven by a convergence of clinical innovation, policy adaptation, and growing community awareness. Expansion is being supported by new product formulations, broadening payer coverage, and positive adoption trends across key geographies. Early adoption in the Americas and an increasing penetration of generic formulations in cost-sensitive regions present substantial opportunities for market participants.

Scope & Segmentation: Comprehensive Analysis Across Product, Channel, and Geography

This report delivers a granular assessment of the pre-exposure prophylaxis landscape, systematically segmenting the market for actionable insight. Key areas of focus include:

  • Product Type: Covers both leading branded therapies (Descovy, Truvada) and a competitive generic segment challenging incumbent pricing and driving broader access.
  • Form: Evaluates injectable and oral dosage forms, spotlighting innovations that address adherence while supporting varying patient lifestyles and preferences.
  • Distribution Channel: Examines hospital, online, and retail pharmacy environments for their impact on patient access and the integration of new technologies.
  • End User: Unpacks adoption drivers across clinics, home care settings, and hospitals, emphasizing the varied approaches to outreach and engagement.
  • Regional Coverage: Analysis includes the Americas, Europe, Middle East & Africa, and Asia-Pacific, highlighting regulatory, infrastructural, and socio-cultural factors shaping uptake.
  • Leading Companies: Focuses on strategies, product portfolios, and partnerships adopted by pharmaceutical innovators including Gilead Sciences, ViiV Healthcare, Viatris, Teva Pharmaceutical Industries, and others.

Key Takeaways: Strategic Insights for Senior Leaders

  • The adoption of long-acting injectable PrEP is redefining patient adherence strategies and improving the scope for personalized medical interventions based on clinical preferences.
  • Digital health platforms, such as telemedicine and mobile adherence tools, are transforming remote access and patient support, especially in under-resourced communities.
  • Branded and generic manufacturers are responding to pricing pressures by introducing differentiated offerings and robust patient support initiatives to sustain competitive advantage.
  • Distribution channel diversification, including the emergence of online and retail pharmacy models, increases accessibility for disparate patient populations and facilitates convenient procurement.
  • Regional discrepancies in policy and infrastructure remain influential, necessitating targeted strategies for successful market penetration and equitable program scale-up.

Tariff Impact: Navigating Supply Chain and Cost Adjustments

The scheduled introduction of United States tariffs in 2025 is expected to influence both production costs and supply chain reliability within the pre-exposure prophylaxis sector. Heightened focus on nearshoring strategies and contract manufacturing is emerging as a response to potential cost volatility. Non-governmental agencies and funding partners must reassess budget allocations to sustain delivery in vulnerable populations, highlighting the interconnectedness of trade policy and public health outcomes.

Methodology & Data Sources

This report leverages a blend of primary research—covering interviews with clinical experts, payers, and program managers—and secondary intelligence, including peer-reviewed studies and authoritative databases. Data triangulation methods ensure that both qualitative and quantitative findings are validated and reflect current market realities.

Why This Report Matters

Senior decision-makers will benefit from:

  • Immediate visibility into the evolving drivers of PrEP adoption, therapeutic development, and policy integration.
  • Guidance on optimizing supply chains, pricing strategies, and partnership models in a rapidly changing competitive context.
  • Actionable recommendations tailored to navigating regulatory shifts and investing in technologies that enhance patient and provider engagement.

Conclusion: Forward-Looking Perspectives

As new entrants, shifting policies, and advancing technology reshape the pre-exposure prophylaxis market, agile strategies will be essential. Continued collaboration and innovative delivery channels will underpin the sector’s progress in preventative health.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. FDA approval of novel long-acting injectable cabotegravir reshaping PrEP adherence strategies
5.2. Increasing uptake of on-demand oral PrEP among young key populations driving demand dynamics
5.3. Strategic partnerships between biotech startups and global NGOs expanding PrEP access in Africa and Asia
5.4. Integration of telehealth platforms for remote PrEP counseling and adherence monitoring at scale
5.5. Emergence of generic tenofovir disoproxil fumarate increases price competitiveness in low income countries
5.6. Regulatory incentives accelerating development of dual HIV and STI prophylactic combination therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pre-Exposure Prophylaxis Market, by Product Type
8.1. Introduction
8.2. Branded
8.2.1. Descovy
8.2.2. Truvada
8.3. Generic
9. Pre-Exposure Prophylaxis Market, by Form
9.1. Introduction
9.2. Injectable
9.3. Oral
10. Pre-Exposure Prophylaxis Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Pre-Exposure Prophylaxis Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
12. Americas Pre-Exposure Prophylaxis Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Pre-Exposure Prophylaxis Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Pre-Exposure Prophylaxis Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Gilead Sciences, Inc.
15.3.2. ViiV Healthcare Limited
15.3.3. Viatris Inc.
15.3.4. Teva Pharmaceutical Industries Limited
15.3.5. Cipla Limited
15.3.6. Hetero Healthcare Limited
15.3.7. Dr. Reddy's Laboratories Limited
15.3.8. Aurobindo Pharma Limited
15.3.9. Sun Pharmaceutical Industries Limited
15.3.10. Lupin Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PRE-EXPOSURE PROPHYLAXIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PRE-EXPOSURE PROPHYLAXIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PRE-EXPOSURE PROPHYLAXIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PRE-EXPOSURE PROPHYLAXIS MARKET: RESEARCHAI
FIGURE 24. PRE-EXPOSURE PROPHYLAXIS MARKET: RESEARCHSTATISTICS
FIGURE 25. PRE-EXPOSURE PROPHYLAXIS MARKET: RESEARCHCONTACTS
FIGURE 26. PRE-EXPOSURE PROPHYLAXIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PRE-EXPOSURE PROPHYLAXIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DESCOVY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DESCOVY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY TRUVADA, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY TRUVADA, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 67. CANADA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 68. CANADA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 69. CANADA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 70. CANADA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 71. CANADA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 72. CANADA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 73. CANADA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. CANADA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. CANADA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. CANADA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. MEXICO PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. MEXICO PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. MEXICO PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 80. MEXICO PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 81. MEXICO PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 82. MEXICO PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 83. MEXICO PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. MEXICO PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. MEXICO PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. MEXICO PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. BRAZIL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. BRAZIL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. ARGENTINA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 98. ARGENTINA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED KINGDOM PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 122. UNITED KINGDOM PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. GERMANY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. GERMANY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. GERMANY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 132. GERMANY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 133. GERMANY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 134. GERMANY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 135. GERMANY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. GERMANY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. GERMANY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. GERMANY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. FRANCE PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. FRANCE PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. FRANCE PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 142. FRANCE PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 143. FRANCE PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 144. FRANCE PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 145. FRANCE PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. FRANCE PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. FRANCE PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. FRANCE PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. RUSSIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. RUSSIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. RUSSIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 152. RUSSIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. ITALY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. ITALY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. ITALY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 162. ITALY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 163. ITALY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 164. ITALY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 165. ITALY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. ITALY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. ITALY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. ITALY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. SPAIN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. SPAIN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. SPAIN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 172. SPAIN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 173. SPAIN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 174. SPAIN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 175. SPAIN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. SPAIN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. SPAIN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. SPAIN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. SAUDI ARABIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 192. SAUDI ARABIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. SOUTH AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 202. SOUTH AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. DENMARK PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. DENMARK PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. DENMARK PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 212. DENMARK PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 213. DENMARK PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 214. DENMARK PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 215. DENMARK PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. DENMARK PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. DENMARK PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. DENMARK PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. NETHERLANDS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. NETHERLANDS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. NETHERLANDS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 222. NETHERLANDS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. QATAR PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. QATAR PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. QATAR PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 232. QATAR PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 233. QATAR PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 234. QATAR PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 235. QATAR PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. QATAR PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. QATAR PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. QATAR PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. FINLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. FINLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. FINLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 242. FINLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 243. FINLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 244. FINLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 245. FINLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. FINLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. FINLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. FINLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. SWEDEN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. SWEDEN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. SWEDEN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 252. SWEDEN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. NIGERIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. NIGERIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. NIGERIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 262. NIGERIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. EGYPT PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. EGYPT PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. EGYPT PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 272. EGYPT PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 273. EGYPT PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 274. EGYPT PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 275. EGYPT PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. EGYPT PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. EGYPT PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. EGYPT PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. TURKEY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. TURKEY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. TURKEY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 282. TURKEY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 283. TURKEY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 284. TURKEY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 285. TURKEY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. TURKEY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. TURKEY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. TURKEY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. ISRAEL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. ISRAEL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. ISRAEL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 292. ISRAEL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 293. ISRAEL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 294. ISRAEL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. NORWAY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. NORWAY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. NORWAY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 302. NORWAY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 303. NORWAY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 304. NORWAY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 305. NORWAY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. NORWAY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. NORWAY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. NORWAY PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. POLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. POLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. POLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 312. POLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 313. POLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 314. POLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 315. POLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. POLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. POLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. POLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. SWITZERLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. SWITZERLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. SWITZERLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 322. SWITZERLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 323. SWITZERLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 324. SWITZERLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 325. SWITZERLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. SWITZERLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. SWITZERLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. SWITZERLAND PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 330. ASIA-PACIFIC PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2018-2024 (USD MILLION)
TABLE 332. ASIA-PACIFIC PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY BRANDED, 2025-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 334. ASIA-PACIFIC PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC PRE-EXPOSURE PROPHYLAXIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 20

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pre-Exposure Prophylaxis market report include:
  • Gilead Sciences, Inc.
  • ViiV Healthcare Limited
  • Viatris Inc.
  • Teva Pharmaceutical Industries Limited
  • Cipla Limited
  • Hetero Healthcare Limited
  • Dr. Reddy's Laboratories Limited
  • Aurobindo Pharma Limited
  • Sun Pharmaceutical Industries Limited
  • Lupin Limited

Related Topics

Related Reports

Human Immunodeficiency Virus (HIV): Seven-Market Drug Forecast and Market Analysis - Product Image

Human Immunodeficiency Virus (HIV): Seven-Market Drug Forecast and Market Analysis

  • Report
  • 134 Pages
  • Global
From
Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033 - Product Image

Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033

  • Report
  • 59 Pages
  • Global
From
Anti-Retroviral Drugs - Global Strategic Business Report - Product Image

Anti-Retroviral Drugs - Global Strategic Business Report

  • Report
  • 280 Pages
  • Global
From
Human Immunodeficiency Virus Type-1 Market - A Global and Regional Analysis: Focus on Drug Class and Regional Analysis - Analysis and Forecast, 2025-2035 - Product Image

Human Immunodeficiency Virus Type-1 Market - A Global and Regional Analysis: Focus on Drug Class and Regional Analysis - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Tenofovir Disoproxil Fumarate Tablets Market - Global Forecast to 2030 - Product Image

Tenofovir Disoproxil Fumarate Tablets Market - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.